Monica Chen (@monicachenmd) 's Twitter Profile
Monica Chen

@monicachenmd

Medical oncology doctor at Memorial Sloan Kettering Cancer Center. Interested in melanoma and early drug development

ID: 1552872482922799106

calendar_today29-07-2022 04:24:19

27 Tweet

234 Followers

282 Following

Jill Feldman (@jillfeldman4) 's Twitter Profile Photo

I told this wicked smart, compassionate & fun group of young investigators that I’m counting on them to save my life! Of course I said no pressure, but I have immense faith in them & would trust my life in their hands #FutureOfLungCancerIsBright #LCSM #LCAM #EGFRSummit22

I told this wicked smart, compassionate & fun group of young investigators that I’m counting on them to save my life! 
Of course I said no pressure, but I have immense faith in them & would trust my life in their hands
#FutureOfLungCancerIsBright 
#LCSM #LCAM #EGFRSummit22
Monica Chen (@monicachenmd) 's Twitter Profile Photo

Honored to receive a 2023 Conquer Cancer Young Investigator Grant to investigate novel targeted therapies for squamous cell lung cancer. Grateful to have incredible mentors and an amazing patient advocate. Congrats to all the awardees! Memorial Sloan Kettering Cancer Center Jill Feldman #ASCO2023

Tom Newsom-Davis (@tnewsomdavis) 's Twitter Profile Photo

Can’t claim responsibility for this, and thank you for person who sent it to me, but reckon this is the most useful #ASCO23 list there is: Free food available in Exhibition Hall:

Can’t claim responsibility for this, and thank you for person who sent it to me, but reckon this is the most useful #ASCO23 list there is:

Free food available in Exhibition Hall:
Alexander Drilon MD (@alexdrilon) 's Twitter Profile Photo

Repotrectinib is FDA approved for ROS1+ lung cancers in the TKI naive and pretreated settings. Many thanks to the patients, advocates, and study teams around the world who made this possible. onclive.com/view/fda-appro…

Allison Betof Warner, MD, PhD (@drbetofmdphd) 's Twitter Profile Photo

Lifileucel (TIL cell therapy from Iovance Biotherapeutics) is now FDA approved for advanced PD-1 refractory melanoma!!! The melanoma community is so grateful to the patients, caregivers, and clinicians who have made the clinical trials of this therapy possible and got lifileucel to approval.

Lifileucel (TIL cell therapy from <a href="/IovanceBio/">Iovance Biotherapeutics</a>) is now FDA approved for advanced PD-1 refractory melanoma!!! The melanoma community is so grateful to the patients, caregivers, and clinicians who have made the clinical trials of this therapy possible and got lifileucel to approval.
Monica Chen (@monicachenmd) 's Twitter Profile Photo

Great to present today at the IASLC #TTLC24 meeting on a huge team effort to find better treatments for patients with metastatic EGFR/TP53/RB1 lung cancer in the city I grew up in. Memorial Sloan Kettering Cancer Center EGFR Resisters Helena Yu

Sandra P D'Angelo, MD (@sandrapdangelo) 's Twitter Profile Photo

The registrational enabling Spearhead-1 study shows that afami-cel, an engineered T cell targeting MAGEA4, has promising efficacy in synovial sarcoma and MRCLS paving the way for T cell therapy in solid tumors. Memorial Sloan Kettering Cancer Center MSK Department of Medicine Sarcoma Service at Memorial Sloan Kettering sciencedirect.com/science/articl…

MSK Department of Medicine (@msk_deptofmed) 's Twitter Profile Photo

Today at #AACR24, Yonina Murciano-Goroff will chair a session on novel approaches for targeted therapies. Fellows Monica Chen & Antoine Desilets, MD, MSc will also present. Not to be missed! Memorial Sloan Kettering Cancer Center 2:30 p.m. PT | Ballroom 6 A - Upper Level - Convention Center buff.ly/43OXQJ7

Today at #AACR24, <a href="/YoninaMG/">Yonina Murciano-Goroff</a> will chair a session on novel approaches for targeted therapies. Fellows <a href="/MonicaChenMD/">Monica Chen</a> &amp; <a href="/desiletsantoine/">Antoine Desilets, MD, MSc</a> will also present. Not to be missed! <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a> 
2:30 p.m. PT | Ballroom 6 A - Upper Level - Convention Center 
buff.ly/43OXQJ7
Monica Chen (@monicachenmd) 's Twitter Profile Photo

Incredible presentation by Helena Yu! We need more trials for patients with leptomeningeal disease and active brain metastasis

Monica Chen (@monicachenmd) 's Twitter Profile Photo

Immensely grateful to AIM at Melanoma Foundation for the opportunity to attend my first Women in Melanoma meeting and connect with such passionate peers and women heroes. Thank you Sam for organizing such an incredible event! #WIM